Genome Editing in Cardiovascular Diseases

Genome editing is a powerful tool to study specific mutations or genes involved in the development and progression of cardiovascular disease. Discover the latest research on Genome Editing in Cardiovascular Disease here.

June 9, 2020
Open Access

Recent Advances in the Treatment of Sickle Cell Disease

Frontiers in Physiology
Gabriel Salinas Cisneros, Swee L Thein
June 13, 2020

Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids

Stem Cell Reports
Amelia LaneMichael E Cheetham
June 4, 2020

Culture and differentiation of purified human adipose-derived stem cells by membrane filtration via nylon mesh filters

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Jiandong PanHao Chen
June 2, 2020

Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System

Molecular Therapy. Methods & Clinical Development
Jenny ShapiroA Hendel
June 24, 2020

Dppa2 and Dppa4 counteract de novo methylation to establish a permissive epigenome for development

Nature Structural & Molecular Biology
Kristjan H Gretarsson, Jamie A Hackett
June 4, 2020
Open Access

Loss of the transcription factor MAFB limits β-cell derivation from human PSCs

Nature Communications
Ronan RussellMatthias Hebrok
July 3, 2020
Open Access

Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells

Frontiers in Cell and Developmental Biology
Zuzana BudkovaBylgja Hilmarsdottir
June 14, 2020
Open Access

Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing

Hanseul ParkJongpil Kim
June 28, 2020
Open Access

Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery

Human Genomics
Claudia De MasiFederica Sangiuolo
June 3, 2020

Natural Killer Cell Immunotherapy for Osteosarcoma

Advances in Experimental Medicine and Biology
Brian P TulliusDean A Lee
July 3, 2020

Next-generation stem cells - ushering in a new era of cell-based therapies

Nature Reviews. Drug Discovery
Erin A Kimbrel, Robert Lanza
June 19, 2020
Open Access

CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis

International Journal of Molecular Sciences
Evgenia SarrouKaren Keeshan
July 1, 2020
Open Access

Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking

Nature Biotechnology
Samuele FerrariLuigi Naldini

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2020 Meta ULC. All rights reserved